Demant CEO won't rule out dismissals following divestment of implant division
The 700 people employed at Demant’s surgical division, Oticon Medical, have an uncertain future ahead after the parent company announced its intention to sell the unit to Cochlear. CEO Søren Nielsen says some people might be transferred and others reshuffled within Demant, but he won’t reject having to resort to dismissals.
by ALBERT RØNNING-ANDERSSON, translated by daniel pedersen
If any worried faces were detected this morning among the around 700 people working at the implant division of hearing aid manufacturer Demant, it is well understood why.